• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

Moderna vaccine full FDA approval
Health
Moderna COVID-19 vaccine gets full approval from the FDA
By Matthew Perrone and The Associated PressJanuary 31, 2022
Merck covid 19 pill
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
Pfizer logo pill
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By Matthew Perrone and The Associated PressDecember 22, 2021
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
Health
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
By Lauran Neergaard, Matthew Perrone and The Associated PressNovember 19, 2021
Pfizer CEO Albert Bourla
Health
Pfizer seeks emergency FDA authorization for COVID-19 pill
By Matthew Perrone and The Associated PressNovember 16, 2021
FDA authorizes COVID vaccine for kids ages 5 to 11
Health
FDA authorizes COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 29, 2021
Vaccines for kids
Health
FDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 26, 2021
Moderna vaccine
Health
FDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 20, 2021
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
Health
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 14, 2021
FDA will not make a decision on Merck’s COVID antiviral pill until December
Health
FDA will not make a decision on Merck’s COVID antiviral pill until December
By Matthew Perrone and The Associated PressOctober 14, 2021
FDA debates timeline for administering Johnson & Johnson booster shots
Health
FDA debates timeline for administering Johnson & Johnson booster shots
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 13, 2021
FDA panel will advise on Johnson & Johnson booster shots this week
Health
FDA panel will advise on Johnson & Johnson booster shots this week
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By Matthew Perrone and The Associated PressOctober 1, 2021
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
Health
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
By Matthew Perrone, Lauran Neergaard, Mike Stobbe and The Associated PressSeptember 22, 2021
1...
  • 4
  • 5
  • 6
  • 7
  • 8
8
Most Popular
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Success
Despite a $150 million net worth, Quentin Tarantino refuses to give a ‘penny’ of his fortune to his mother: ‘No house, no Cadillac’placeholder alt text
By Orianna Rosa RoyleOctober 28, 2026
Economy
For the first time since 1992, a Fed governor and president dissented together, as Kevin Warsh says the 'monetary medicine' is starting to workplaceholder alt text
By Catherina GioinoOctober 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.